254 related articles for article (PubMed ID: 34476212)
1. Multi-Omics Analysis of the Expression and Prognosis for FKBP Gene Family in Renal Cancer.
Sun Z; Qin X; Fang J; Tang Y; Fan Y
Front Oncol; 2021; 11():697534. PubMed ID: 34476212
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract][Full Text] [Related]
3. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
4. High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10.
Ma W; Li X; Yang L; Pan J; Chen Y; Lu Y; Dong X; Li D; Gan W
J Transl Med; 2022 Dec; 20(1):554. PubMed ID: 36463181
[TBL] [Abstract][Full Text] [Related]
5. A Novel Biomarker, FKBP10, for Poor Prognosis Prediction in Patients with Clear Cell Renal Cell Carcinoma.
Xiao Y; Li S; Zhang M; Liu X; Ju G; Hou J
Evid Based Complement Alternat Med; 2022; 2022():5490644. PubMed ID: 35722147
[TBL] [Abstract][Full Text] [Related]
6. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
Front Oncol; 2020; 10():788. PubMed ID: 32528886
[No Abstract] [Full Text] [Related]
7. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
8. Subcellular Expression Patterns of FKBP Prolyl Isomerase 10 (FKBP10) in Colorectal Cancer and Its Clinical Significance.
Fu Y; Chen J; Ma X; Chang W; Zhang X; Liu Y; Shen H; Hu X; Ren AJ
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511172
[TBL] [Abstract][Full Text] [Related]
9. Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC).
Bai X; Cao Y; Yan X; Tuoheti K; Du G; Chen Z; Wu H; Guo L; Liu T
Pharmgenomics Pers Med; 2021; 14():1717-1729. PubMed ID: 35002290
[TBL] [Abstract][Full Text] [Related]
10. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
Front Oncol; 2021; 11():630706. PubMed ID: 33968730
[TBL] [Abstract][Full Text] [Related]
11. An immune infiltration-related prognostic model of kidney renal clear cell carcinoma with two valuable markers: CAPN12 and MSC.
Xia G; Wu S; Cui X
Front Oncol; 2023; 13():1161666. PubMed ID: 37025600
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Methylation-Regulating Genes Prognostic Signature to Predict the Prognosis and Aid Immunotherapy of Clear Cell Renal Cell Carcinoma.
Zhang L; Su Z; Hong F; Wang L
Front Cell Dev Biol; 2022; 10():832803. PubMed ID: 35309925
[TBL] [Abstract][Full Text] [Related]
14. PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis.
Luo Y; Chen L; Wang G; Qian G; Liu X; Xiao Y; Wang X; Qian K
J Cancer; 2019; 10(10):2319-2331. PubMed ID: 31258735
[TBL] [Abstract][Full Text] [Related]
15. Penetrating Exploration of Prognostic Correlations of the FKBP Gene Family with Lung Adenocarcinoma.
Wang CC; Shen WJ; Anuraga G; Hsieh YH; Khoa Ta HD; Xuan DTM; Shen CF; Wang CY; Wang WJ
J Pers Med; 2022 Dec; 13(1):. PubMed ID: 36675710
[TBL] [Abstract][Full Text] [Related]
16. Up-regulated PIF1 predicts poor clinical outcomes and correlates with low immune infiltrates in clear cell renal cell carcinoma.
Cai T; Wang N; Meng P; Sun W; Cui Y
Front Genet; 2022; 13():1058040. PubMed ID: 36685888
[No Abstract] [Full Text] [Related]
17. The immune-related biomarker TEK inhibits the development of clear cell renal cell carcinoma (ccRCC) by regulating AKT phosphorylation.
Chen S; Yu M; Ju L; Wang G; Qian K; Xiao Y; Wang X
Cancer Cell Int; 2021 Feb; 21(1):119. PubMed ID: 33602230
[TBL] [Abstract][Full Text] [Related]
18. Biomarker Screening and Prognostic Significance Analysis for Renal Cell Carcinoma.
Meng X; Yuan H; Li W; Xiao W; Zhang X
Int J Gen Med; 2021; 14():5255-5267. PubMed ID: 34522125
[TBL] [Abstract][Full Text] [Related]
19. FAM72 family proteins as poor prognostic markers in clear cell renal carcinoma.
Gou H; Chen P; Wu W
Biochem Biophys Rep; 2023 Sep; 35():101506. PubMed ID: 37457361
[TBL] [Abstract][Full Text] [Related]
20. Identification of an independent immune-genes prognostic index for renal cell carcinoma.
Li G; Wei X; Su S; Wang S; Wang W; Wang Y; Meng X; Xia J; Song N; Qin C
BMC Cancer; 2021 Jun; 21(1):746. PubMed ID: 34187413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
